Cytokinetics Inc. buy Royal Bank of Canada
Start price
07.05.25
/
50%
€29.40
Target price
07.05.26
€70.52
Performance (%)
93.88%
Price
14:55
€57.00
Summary
This prediction is currently active. With a performance of 93.88% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 07.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -2.564% | -2.564% |
| iShares Core DAX® | 1.330% | -1.723% |
| iShares Nasdaq 100 | 1.099% | -2.569% |
| iShares Nikkei 225® | 1.265% | -6.613% |
| iShares S&P 500 | 1.000% | -0.871% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Royal Bank of Canada from $82.00 to $80.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat